Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares fell 18.9 percent to touch a new 52-week low of $5.68 after the company issued a profit warning for the third quarter.
Adaptimmune Therapeutics PLC - ADR (NASDAQ: ADAP) shares...
BRUSSELS (dpa-AFX) - Novo Nordisk (NVO) announced the receipt of a Complete
Response Letter from the US Food and Drug Administration regarding the New Drug
Application for faster-acting insulin aspart. The NDA for faster-acting insulin
Danish pharmaceutical company Novo Nordisk is moving into the complex and more expensive business of inventing new forms of insulin, which would bring it closer to the riskier drug-discovery activities of the wider pharmaceutical industry.
The International Monetary Fund’s (IMF) report into corporate governance in emerging markets, published on Wednesday (September 28), praises BM&FBOVESPA as a groundbreaker in regard to its Novo Mercado.
Selim Elekdag, IMF economist and the...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Novo Nordisk A/S (NVO):